MA20602A1 - Composes chimiquement actif et procede pour sa preparation - Google Patents

Composes chimiquement actif et procede pour sa preparation

Info

Publication number
MA20602A1
MA20602A1 MA20828A MA20828A MA20602A1 MA 20602 A1 MA20602 A1 MA 20602A1 MA 20828 A MA20828 A MA 20828A MA 20828 A MA20828 A MA 20828A MA 20602 A1 MA20602 A1 MA 20602A1
Authority
MA
Morocco
Prior art keywords
preparation
active compounds
chemically active
chemically
compounds
Prior art date
Application number
MA20828A
Other languages
English (en)
Original Assignee
Conpharm Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conpharm Ab filed Critical Conpharm Ab
Publication of MA20602A1 publication Critical patent/MA20602A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA20828A 1984-12-28 1985-12-26 Composes chimiquement actif et procede pour sa preparation MA20602A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8406660 1984-12-28

Publications (1)

Publication Number Publication Date
MA20602A1 true MA20602A1 (fr) 1986-07-01

Family

ID=20358339

Family Applications (1)

Application Number Title Priority Date Filing Date
MA20828A MA20602A1 (fr) 1984-12-28 1985-12-26 Composes chimiquement actif et procede pour sa preparation

Country Status (23)

Country Link
US (1) US4788216A (fr)
EP (1) EP0207124B1 (fr)
JP (2) JPH0720966B2 (fr)
CN (1) CN1006795B (fr)
AP (1) AP32A (fr)
AT (1) ATE68186T1 (fr)
AU (1) AU585936B2 (fr)
CA (1) CA1255230A (fr)
DE (1) DE3584370D1 (fr)
DK (1) DK169506B1 (fr)
DZ (1) DZ876A1 (fr)
EG (1) EG17788A (fr)
ES (1) ES8701761A1 (fr)
FI (1) FI89330C (fr)
GR (1) GR853145B (fr)
HU (1) HU201672B (fr)
IL (1) IL77456A (fr)
MA (1) MA20602A1 (fr)
NO (1) NO863329D0 (fr)
PT (1) PT81760B (fr)
TN (1) TNSN86004A1 (fr)
WO (1) WO1986004062A1 (fr)
ZA (1) ZA859881B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4644072A (en) * 1985-04-12 1987-02-17 Bristol-Myers Company Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
AU632796B2 (en) * 1989-02-23 1993-01-14 University Of North Carolina At Chapel Hill, The Etoposide analogues
SE464167B (sv) 1989-07-31 1991-03-18 Analytecon Sa Topisk farmaceutisk beredning av podophyllotoxin
US5332811A (en) * 1989-09-12 1994-07-26 The University Of North Carolina At Chapel Hill Etopside analogs
US5338867A (en) * 1992-04-24 1994-08-16 Genelabs Technologies, Inc. Preparation of 4β- amino podophyllotoxin compounds
SE9301831D0 (sv) * 1993-05-28 1993-05-28 Analytecon S A Pharmaceutical compositions
GB9422947D0 (en) * 1994-11-14 1995-01-04 Univ Salamanca Immunosuppressive cyclolignan derivatives
US6051721A (en) * 1997-10-02 2000-04-18 The Board Of Regents Of The University Of Nebraska Ring E-modified analogues of(-)-podophyllotoxin and etoposide and a method for their synthesis
FI105152B (fi) 1998-07-17 2000-06-30 Eero Saarela Paikallinen kivunlievitysmenetelmä
US6143304A (en) * 1999-08-17 2000-11-07 The University Of Mississippi Enhanced yield of podophyllotoxin from natural products through in situ conversion methods
DE60233601D1 (de) * 2001-06-19 2009-10-15 Axelar Ab Verwendung von bestimmten Cyclolignanen
SE0102168D0 (sv) * 2001-06-19 2001-06-19 Karolinska Innovations Ab New use and new compounds
SE0203746D0 (sv) * 2002-12-18 2002-12-18 Karolinska Innovations Ab New compounds
KR20110044947A (ko) * 2008-06-23 2011-05-03 악셀라르 아베 과잉활성 면역계 치료를 위한 사이클로리그난의 용도
WO2013124380A1 (fr) * 2012-02-24 2013-08-29 Nestec S.A. Peltatine destinée à être utilisée pour traiter des troubles inflammatoires chroniques
WO2015028456A1 (fr) * 2013-08-28 2015-03-05 Nestec S.A. Modulateurs des rapp
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA635769A (en) * 1962-01-30 Rutschmann Jurg Amides of podophyllic acid and picropodophyllic acid
SE335139B (fr) * 1964-08-12 1971-05-17 Sandoz Ag
US4122092A (en) * 1977-08-25 1978-10-24 University Of Rochester Total synthesis of (±)-picropodophyllone and (±)-4'-demethylpicropodophyllone
US4567253A (en) * 1984-02-03 1986-01-28 Tony Durst 2-Substituted derivatives of podophyllotoxin and etoposide
GB8424269D0 (en) * 1984-09-26 1984-10-31 Pharma Medica As Isolation and purification of podophyllotoxin

Also Published As

Publication number Publication date
AP8500017A0 (en) 1985-11-01
NO863329L (no) 1986-08-19
FI863482A (fi) 1986-08-27
PT81760B (pt) 1987-11-11
EP0207124B1 (fr) 1991-10-09
FI89330B (fi) 1993-06-15
JP2572558B2 (ja) 1997-01-16
US4788216A (en) 1988-11-29
AU585936B2 (en) 1989-06-29
FI89330C (fi) 1993-09-27
JPS62501360A (ja) 1987-06-04
JPH0720966B2 (ja) 1995-03-08
DZ876A1 (fr) 2004-09-13
ZA859881B (en) 1986-09-24
HU201672B (en) 1990-12-28
FI863482A0 (fi) 1986-08-27
DE3584370D1 (de) 1991-11-14
TNSN86004A1 (fr) 1990-01-01
WO1986004062A1 (fr) 1986-07-17
JPH07173063A (ja) 1995-07-11
DK408186A (da) 1986-08-27
ES8701761A1 (es) 1986-12-01
PT81760A (en) 1986-01-02
AU5300386A (en) 1986-07-29
EG17788A (en) 1990-12-30
CA1255230A (fr) 1989-06-06
ATE68186T1 (de) 1991-10-15
IL77456A0 (en) 1986-08-31
GR853145B (fr) 1986-04-29
IL77456A (en) 1989-07-31
NO863329D0 (no) 1986-08-19
DK169506B1 (da) 1994-11-14
CN1006795B (zh) 1990-02-14
CN85109666A (zh) 1986-10-29
DK408186D0 (da) 1986-08-27
AP32A (en) 1988-12-07
ES550504A0 (es) 1986-12-01
HUT47582A (en) 1989-03-28
EP0207124A1 (fr) 1987-01-07

Similar Documents

Publication Publication Date Title
FR2568472B1 (fr) Preparations pharmaceutiques retard et procede pour les fabriquer
FR2640801B1 (fr) Polyelectrolyte solide et procede pour sa preparation
MA20602A1 (fr) Composes chimiquement actif et procede pour sa preparation
MA21120A1 (fr) Procede de preparation de composes pharmalogiquement actifs.
FR2523308B1 (fr) Electrode selective d'ion et procede pour sa preparation
IL65799A (en) 2-(2-benzyl-3-mercaptopropionyl-amino)-4-alkylthiobutanol or-butanoic acid derivatives
FR2560882B1 (fr) Procede pour la preparation de carbamate de cellulose
FR2550788B1 (fr) Nouveau procede de preparation d'a-6-desoxytetracyclines
FR2568867B1 (fr) Procede de preparation de tetrafluorure d'uranium
MA21413A1 (fr) Nouveau procede de preparation d'alcoxy-guanine
FR2571713B1 (fr) Procede de preparation de titanates, zirconates et stannates
FR2573070B1 (fr) Procede de preparation de composes carbonyles
FR2522266B1 (fr) Procede de preparation d'un agent fibrinolytiquement actif et agent obtenu
PT83989A (fr) Procede de preparation de fongicides a groupes triazole et oligoether et de leurs associations
FR2556340B1 (fr) Procede catalytique de preparation d'hexafluoroacetone
MA20379A1 (fr) Procede de production de 2-oxindole-1-carboxamides et de composes intermediaires correspondants
FR2562070B1 (fr) Procede de preparation de 2-amino-s-triazines
FR2564105B1 (fr) Composition detergente liquide et procede pour sa preparation.
FR2564460B1 (fr) Methyl 2-(2-hydroperoxy-2-propyl)naphtalene-6-carboxylate et procede pour sa preparation
HUT41218A (en) Fungicides containing as active substance derivatives of phenil-sulphonil-asole and process for production of the active substance
ZA85793B (en) Optically active phenozypropionic acid derivatives
MC1740A1 (fr) Glyocides et procede pour leur preparation
RO88451A2 (fr) Derives de l'acide 7-aminocephalosporanique et procede de preparation
FR2560199B1 (fr) Procede de preparation de l'i-brassicasterol
FR2566776B1 (fr) Procede de preparation de metalloporphyrines